Journals / Turkish Thoracic Journal / 2019 / Cilt: 20 - Sayı: 4

Factors Affecting Cost of Patients with Severe CommunityAcquired Pneumonia in Intensive Care Unit

Pages
216–223
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The need for mechanical ventilation during treatment and the presence of sepsis/septic shock are additional factors that increase the cost.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: The aim of this study is to investigate the factors affecting cost in patients with severe community-acquired pneumonia(CAP) who were admitted to the intensive care unit (ICU).MATERIALS AND METHODS: This retrospective cohort study was conducted between January 2013 and December 2016.
📊
Key Findings & Data:A total of 291sequential patients with severe CAP were included in the study.
💡
Conclusion & Impact:The need for mechanical ventilation during treatment and the presence of sepsis/septic shock are additional factors that increase the cost.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVES: The aim of this study is to investigate the factors affecting cost in patients with severe community-acquired pneumonia(CAP) who were admitted to the intensive care unit (ICU).MATERIALS AND METHODS: This retrospective cohort study was conducted between January 2013 and December 2016. A total of 291sequential patients with severe CAP were included in the study. Patients’ demographic and clinical data; the need for invasive mechanicalventilation or non-invasive mechanical ventilation; intensive care severity (ICU) scores, including Acute Physiology and Chronic HealthEvaluation (APACHE II), Sepsis-related Organ Failure Assessment, Quick SOFA, pneumonia severity index (PSI); and Confusion, Urea,Respiratory Rate, and Blood Pressure-65 (CURB-65) scores were obtained from medical records and recorded for all cases.RESULTS: The mean age of 291 patients was 68.4±16.8 years, and 61% were female. The median length of ICU stay was 7 days. Forty-sixpercent of patients had chronic obstructive pulmonary disease (COPD), and 42% had hypertension. The mean cost of each hospitalization was US$ 2722 (TL 5578). The highest cost was found in the group of patients aged 50–59 years, and the lowest cost was found in thepatients aged 20 points), and CURB-65 score were higher. The presence of COPD, atrial fibrillation, congestive heart failure, hypoalbuminemia, mental state deterioration, in-hospital mortality, severe sepsis, septic shock, mechanical ventilation requirement,and haloperidol and vasopressor usage were associated with higher cost, while the use of florokinolon was associated with lower cost.CONCLUSION: The presence of certain comorbidities and high disease severity in patients with severe CAP hospitalized in ICU increasethe cost of inpatient treatment. The need for mechanical ventilation during treatment and the presence of sepsis/septic shock are additional factors that increase the cost.

🔖

Cite This Article

Karakurt, Z., Aksoy, E., Cengiz, M., Çakın, Ö., Gümüş, A., Ergan, B., Çilli, A. (2022). Factors Affecting Cost of Patients with Severe CommunityAcquired Pneumonia in Intensive Care Unit. Turkish Thoracic Journal, Cilt: 20 - Sayı: 4, 216–223. https://ajindex.com/articles/654658

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Torres A, Blasi F, Dartois N, et al. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax 2015
  2. [CrossRef] 2. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005
  3. [CrossRef] 3. Özol D, Bacakoğlu F, Öktem S, et al. Ciddi toplum kökenli pnömonilerin prognozunda klinik. Turk Thorac J 2000
  4. Shorr AF, Bodi M, Rodriguez A, et al. Impact of antibiotic guideline compliance on duration of mechanical ventilation in critically ill patients with community-acquired pneumonia. Chest 2006
  5. [CrossRef] 5. Barlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000
  6. Guest JF, Morris A. Community-acquired pneumonia: The annual cost to the National Health Service in the UK. Eur Respir J 1997
  7. [CrossRef] 7. Menéndez R, Cremades MJ, Martínez-Moragón E, et al. Duration of length of stay in pneumonia: Influence of clinical factors and hospital type. Eur Respir J 2003
  8. [CrossRef] 8. Özlü T, Bülbül Y, Özsu S. Ulusal verilerle toplum kökenli pnömoniler. Tuberk Toraks 2007
  9. Çilli A, Özdemir T, Öğüş C, et al. Ciddi toplum kökenli pnömonide etyoloji ve prognostik faktörler. Tuberk Toraks 2001
  10. Ediger D, Uzaslan AEK, Yüksel E, et al. Yoğun bakım biriminde izlenen pnömonili olguların değerlendirilmesi. Akciğer Arşivi 2005
  11. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985
  12. [CrossRef] 12. Vincent J, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996
  13. [CrossRef] 13. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016
  14. [CrossRef] 14. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997
  15. [CrossRef] 15. Barlow G, Nathwani D, Davey P. The CURB